168 related articles for article (PubMed ID: 32622780)
1. Impact of invasive nodal staging on regional and distant recurrence rates after SBRT for inoperable stage I NSCLC.
Kennedy WR; Samson PP; Gabani P; Nikitas J; Bradley JD; Roach MC; Robinson CG
Radiother Oncol; 2020 Sep; 150():206-210. PubMed ID: 32622780
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of invasive mediastinal nodal staging versus positron emission tomography staging alone for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
Schonewolf CA; Verma V; Post CM; Berman AT; Frick MA; Vachani A; Lin C; Simone CB
Lung Cancer; 2018 Mar; 117():53-59. PubMed ID: 28800837
[TBL] [Abstract][Full Text] [Related]
3. The role of endobronchial ultrasound-guided transbronchial needle aspiration in stereotactic body radiation therapy for non-small cell lung cancer.
Hashimoto K; Daddi N; Giuliani M; Hope A; Le LW; Czarnecka K; Cypel M; Pierre A; de Perrot M; Darling G; Waddell TK; Keshavjee S; Yasufuku K
Lung Cancer; 2018 Sep; 123():1-6. PubMed ID: 30089578
[TBL] [Abstract][Full Text] [Related]
4. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
[TBL] [Abstract][Full Text] [Related]
5. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
[TBL] [Abstract][Full Text] [Related]
6. Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).
Vilmann P; Clementsen PF; Colella S; Siemsen M; De Leyn P; Dumonceau JM; Herth FJ; Larghi A; Vazquez-Sequeiros E; Hassan C; Crombag L; Korevaar DA; Konge L; Annema JT
Endoscopy; 2015 Jun; 47(6):545-59. PubMed ID: 26030890
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
[TBL] [Abstract][Full Text] [Related]
8. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in the Nodal Staging of Stereotactic Ablative Body Radiotherapy Patients.
Vial MR; Khan KA; O'Connell O; Peng SA; Gomez DR; Chang JY; Rice DC; Mehran R; Jimenez CJ; Grosu HB; Ost DE; Eapen GA
Ann Thorac Surg; 2017 May; 103(5):1600-1605. PubMed ID: 28027732
[TBL] [Abstract][Full Text] [Related]
9. Invasive Nodal Staging via Endobronchial Ultrasound and Outcome in Patients Treated with Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer - Results from a Single Institution Study.
George B; Baydoun A; Bhat S; Bailey L; Arsenault T; Sun Y; Zhang Y; Zheng Y; Vempati P; Podder T; Biswas T
Clin Lung Cancer; 2024 Feb; ():. PubMed ID: 38553326
[TBL] [Abstract][Full Text] [Related]
10. Timing of fluorodeoxyglucose positron emission tomography maximum standardized uptake value for diagnosis of local recurrence of non-small cell lung cancer after stereotactic body radiation therapy.
Tan D; Gill S; Loh N
Cancer Med; 2020 Oct; 9(20):7469-7476. PubMed ID: 32846054
[TBL] [Abstract][Full Text] [Related]
11. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors.
Wink KCJ; van Baardwijk A; Troost EGC; De Ruysscher D
Cancer Treat Rev; 2017 May; 56():8-15. PubMed ID: 28437679
[TBL] [Abstract][Full Text] [Related]
12. Impact of Enlarged Nonhypermetabolic Lymph Nodes on Outcomes After Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer.
Verma V; Schonewolf CA; Cushman TR; Post CM; Doms A; Berman AT; DeVries M; Katz SI; Simone CB
Clin Lung Cancer; 2018 Nov; 19(6):502-510. PubMed ID: 30111509
[TBL] [Abstract][Full Text] [Related]
13. Undetected lymph node metastases in presumed early stage NSCLC SABR patients.
Cerra-Franco A; Diab K; Lautenschlaeger T
Expert Rev Anticancer Ther; 2016 Aug; 16(8):869-75. PubMed ID: 27279087
[TBL] [Abstract][Full Text] [Related]
14. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
15. MEDIASTinal staging of non-small cell lung cancer by endobronchial and endoscopic ultrasonography with or without additional surgical mediastinoscopy (MEDIASTrial): study protocol of a multicenter randomised controlled trial.
Bousema JE; Dijkgraaf MGW; Papen-Botterhuis NE; Schreurs HW; Maessen JG; van der Heijden EH; Steup WH; Braun J; Noyez VJJM; Hoeijmakers F; Beck N; van Dorp M; Claessens NJM; Hiddinga BI; Daniels JMA; Heineman DJ; Zandbergen HR; Verhagen AFTM; van Schil PE; Annema JT; van den Broek FJC;
BMC Surg; 2018 May; 18(1):27. PubMed ID: 29776444
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.
Hoopes DJ; Tann M; Fletcher JW; Forquer JA; Lin PF; Lo SS; Timmerman RD; McGarry RC
Lung Cancer; 2007 May; 56(2):229-34. PubMed ID: 17353064
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of positron emission tomography and computed tomography (PET/CT) in detecting nodal metastasis according to histology of non-small cell lung cancer.
Smith DE; Fernandez Aramburu J; Da Lozzo A; Montagne JA; Beveraggi E; Dietrich A
Updates Surg; 2019 Dec; 71(4):741-746. PubMed ID: 31552569
[TBL] [Abstract][Full Text] [Related]
19. The impact of pathologic staging of the hilar/mediastinal nodes on outcomes in patients with early-stage NSCLC receiving stereotactic body radiotherapy.
Mullins BT; Moore DT; Rivera MP; Marks LB; Akulian J; Pearlstein KA; Wang K; Burks AC; Weiner AA
J Thorac Dis; 2021 Feb; 13(2):1045-1054. PubMed ID: 33717577
[TBL] [Abstract][Full Text] [Related]
20. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
